<h1>CCI Approves GSK's Acquisition of 100% Shares in GSK Asia Under Competition Act Section 31(1.</h1> The Competition Commission of India has approved the acquisition by GlaxoSmithKline Consumer Healthcare Overseas Limited and GlaxoSmithKline Consumer Healthcare UK Trading Limited of 100% shareholding in GlaxoSmithKline Asia Private Limited. This transaction involves the collective acquisition of shares and is conducted under Section 31(1) of the Competition Act, 2002. Prior to this acquisition, GlaxoSmithKline Asia will acquire trademarks and rights related to the Iodex and Ostocalcium brands from GlaxoSmithKline Pharmaceuticals Limited. The acquiring entities are part of the GlaxoSmithKline group, engaged in various consumer healthcare activities. A detailed order from the CCI will be issued subsequently.